| | Test parameters | Total | Male | Female | value |
| | Number (%) | 780 (100) | 330 (42.3) | 450 (57.7) | | | Age, mean ± SD | 57.4 ± 9.4 | 57.8 ± 9.5 | 57.3 ± 9.3 | 0.65 | | Age at diagnosis, median (IQR) | 50 (43–56) | 51 (43–60) | 50 (43–78) | 0.08 | | Duration of diabetes, mean ± SD | 9.8 ± 5.6 | 9.9 ± 3.2 | 9.6 ± 8.9 | 0.09 | | Body mass index (kg/m), median (IQR) | 27.5 (24.8–30.9) | 27.0 (24–30.3) | 27.9 (25.1–31.5) | 0.04 | | General obesity (%) | 262 (33.6) | 92 (27.9) | 170 (37.8) | 0.04 | | Waist circumference, cm, median (IQR) | 97 (87–105) | 94 (84–101) | 98 (90–106) | <0.001 | | Central obesity, n (%) | 582 (74.6) | 156 (47.3) | 426 (94.7) | <0.001 | | Fasting blood glucose, median (IQR) | 8.8 (6.7–12.6) | 8.6 (6 .7–12.2) | 9.1 (6.8–13.5) | 0.4 | | Hba1c (%), median (IQR) | 8.1 (6.8–9.6) | 8.1 (6.6–9.8) | 8.1 (6.9–9.6) | 0.92 | | Abnormal glycemic control (>7%) | 716 (66.2) | 220 (66.7) | 286 (63.6) | 0.85 | | Total cholesterol mmol/L, median (IQR) | 5.0 (4.1–6.0) | 5 (4.2–5.9) | 5 (4–6.1) | 0.63 | | Hypercholesterolemia, n (%) | 400 (51.3) | 164 (49.7) | 236 (52.4) | 0.15 | | Triglycerides (mmol/L), median (IQR) | 1.2 (0.9–1.6) | 1.16 (0.85–1.6) | 1.24 (0.94–1.57) | 0.22 | | Hypertriglyceridemia, n (%) | 170 (21.8) | 66 (20.0) | 104 (23.1) | 0.44 | | LDL-C, median (IQR) | 3.2 (2.1–3.9) | 3.1 (2.2–3.8) | 3.2 (2 .1–4.0) | 0.92 | | High LDL, n (%) | 470 (60.3) | 186 (56.4) | 284 (63.1) | 0.18 | | HDL-C, median (IQR) | 1.2 (1–1.5) | 1.1 (1–1.4) | 1.2 (1.0–1.5) | 0.2 | | Low HDL-C, n (%) | 54 (6.9) | 32 (9.6) | 22 (4.9) | 0.007 | | Dyslipidemia, n (%) | 462 (59.2) | 196 (59.4) | 266 (59.1) | 0.12 | | Systolic blood pressure, median (IQR) | 140 (130–150) | 140 (129–150) | 140 (130–150) | 0.43 | | Diastolic blood pressure, median (IQR) | 80 (70–90) | 80 (70–90) | 80 (80–90) | 0.01 | | Hypertension, n (%) | 602 (77.9) | 272 (82.4) | 330 (73.3) | 0.03 | | Alcohol, n (%) | 234 (30.0) | 200 (60.6) | 34 (7.6) | <0.001 | | Current smokers, n (%) | 58 (7.4) | 56 (17.0) | 2 (0.4) | <0.001 | | Framingham CHD risk, %, median (IQR) | 6 (2–12) | 12 (8–20) | 3 (1–6) | <0.001 | | UKPDS CHD risk score, median (IQR) | 4 (0.4–7) | 9.4(5.7–13.4) | 5.8 (3.4–9.6) | <0.001 | | Subclinical hypothyroidism | 64 (8.2) | 14 (4.2) | 50 (11.1) | 0.02 | | Subclinical hyperthyroidism | 22 (2.8) | 14 (4.2) | 8 (1.8) | <0.001 | | Hypothyroidism | 12 (1.6) | 2 (0.6) | 10 (2.2) | 0.08 | | Hyperthyroidism | 4 (0.5) | 2 (0.6) | 2 (0.4) | 0.21 | | Euthyroidism | 678 (86.9) | 298 (90.3) | 380 (84.4) | 0.02 |
|
|
